ReviewFrontiers in cardiovascular medicine2025
Research advances on artificial intelligence assisted diagnosis and risk assessment in cardiovascular disease using retinal imaging.
Review in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Cardiovascular disease (CVD) is the leading cause of death worldwide, and early prediction and prevention are essential to reduce its incidence. In recent years, Artificial Intelligence (AI) techniques have made significant progress in medical imaging analysis, especially in predicting CVD risk from retinal imaging. Methods: As of August 2025, we searched using several electronic databases including PubMed, Web Of Science Core Collection. Screening was performed based on inclusion and exclusion criteria, and 43 papers were finally selected. Results: AI shows great potential in predicting CVD risk from retinal imaging [optical coherence tomography (OCT), optical coherence tomography angiography (OCTA), and color fundus photography (CFP)]. Non-invasive eye examinations combined with AI analysis offer the potential for mass screening and early warning. Conclusions: AI has made significant progress in the field of CVD assisted diagnosis and risk assessment using retinal imaging. Single-modality models have achieved high accuracy, while multimodal models have further enhanced performance. However, challenges remain, including reliance on single-center data and insufficient generalization capabilities. Future steps include building multi-center datasets, developing dynamic risk models, and promoting portable devices for underserved regions. While promising for early CVD prevention, interdisciplinary collaboration is needed to improve generalizability, standardization, and interpretability for higher clinical value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.